• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Keywords » antidepressant

Items Tagged with 'antidepressant'

ARTICLES

Research Update

How Long Should Antidepressants Be Continued After Response?

February 24, 2026
Dee Rapposelli
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Dee Rapposelli. Ms. Rapposelli has no financial relationships with companies related to this material.

Investigators examine how long patients should stay on antidepressants after feeling better—and what factors matter when considering discontinuation.


Read More

Switching Antidepressants: Direct Switch vs. Cross Taper (Med Fact Book Mini-Series, Part 2)

November 4, 2025
Daniel Carlat, MD

Switching antidepressants isn’t hard.

Unless you rush it—or forget the exceptions.

Part 2: Med Fact Book Mini-Series




Read More
1750680639234.jpeg

Beyond the Meds: Addressing the Story Underneath

August 10, 2025
Daniel Carlat, MD

Her business was failing and her marriage was falling apart. She wanted to OD on her insulin.


Read More
Fact Sheet

Antidepressants in Older Adults

August 2, 2025
Rehan Aziz, MD

Dr. Aziz has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

  • SSRIs are the first-line treatment for late-life depression (LLD) because of their favorable side effect profiles and because they also help with frequent co-occurring anxiety.



  • Read More
    Fact Sheet

    Antidepressants in Older Adults

    August 2, 2025
    Rehan Aziz, MD

    Dr. Aziz has no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

  • SSRIs are the first-line treatment for late-life depression (LLD) because of their favorable side effect profiles and because they also help with frequent co-occurring anxiety.




  • Read More
    Research Update

    Some Antidepressants May Help Longer Than Others

    April 1, 2025
    Jeremy Mills, DNP, PMHNP-BC
    From The Carlat Psychiatry Report
    Issue Links: Editorial Information | PDF of Issue

     Jeremy Mills, DNP, PMHNP-BC. Dr. Mills has no financial relationships with companies related to this material.

    A large Danish study ranks antidepressants by their preventative effects.


    Read More
    Clinical Update

    Evidence-Based Options for Treatment-Resistant Depression in Older Adults

    January 1, 2025
    Julia Cromwell, MD
    From The Carlat Geriatric Psychiatry Report
    Issue Links: Editorial Information | PDF of Issue

    Julia Cromwell, MD. Medical director, geriatric and adult inpatient psychiatrist at Mass General Brigham Salem Hospital, Salem, MA.

    Dr. Cromwell has no financial relationships with companies related to this material.

    Treating depression in older adults can be challenging, especially when first-line therapies fail. We review evidence-based strategies for treatment-resistant depression, from medication adjustments and augmentation to neuromodulation and lifestyle interventions.


    Read More
    TCPR_QA_Horowitz Headshot.jpg
    Expert Q&A

    How to Stop a Psychiatric Med

    November 1, 2024
    Mark Horowitz, MBBS, PhD
    From The Carlat Psychiatry Report
    Issue Links: Editorial Information | PDF of Issue

    TCPR_QA_Horowitz Headshot.jpgMark Horowitz, MBBS, PhD

    Research and Development Department, Goodmayes Hospital, North East London NHS Foundation Trust, Essex, UK; Visiting Lecturer in Psychopharmcology, King’s College London. Co-author of The Maudsley Deprescribing Guidelines (Wiley-Blackwell; 2024).

    Dr. Horowitz is cofounder and consultant for Outro Health. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.

    Dr. Horowitz explains the principle, practicalities, and science of tapering psychiatric medications. 


    Read More
    What You Need to Know About Gepirone (Exxua) _ Benefits, Side Effects, and Review of Trials_Thumb.jpg

    What You Need to Know About Gepirone (Exxua) | Benefits, Side Effects, and Review of Trials

    September 27, 2024
    Chris Aiken, MD. and Greg Malzberg, MD
    In this video, Dr. Chris Aiken, Editor-in-Chief of The Carlat Psychiatry Report, provides a comprehensive review of Gepirone, also known as Exxua, a newly FDA-approved antidepressant for major depressive disorder in adults. Gepirone is unique due to its classification as an azipirone, a class of medications that work as serotonin 5-HT1A receptor agonists. 
    Read More
    shutterstock_658205014.jpg

    Viibryd Goes Generic

    April 1, 2024
    Chris Aiken, MD and Kellie Newsome, PMHNP

    Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.




    Read More
    More Articles Tagged with 'antidepressant'
    Carlat Total Access Subscriptions: Get access to every article on the website.

    Complete access to every article you search on the website.

    Shop for Total Access
    Free Psychiatry Updates
    The latest unbiased psychiatric information sent to your inbox.
    Specify Your Interests
    Featured Book
    • MFB8e_SpiralCover.png

      Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

      Updated 2026 prescriber's guide.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • supportive psychotherapy Dalle 11082023.jpg
      Psychology and Social Work

      Treating BPD Series, Episode 2: Transference-Focused Psychotherapy—From Splitting to Coherence with Frank Yeomans, MD, PhD

      In this episode, Dr. Frank Yeomans offers a deep dive into the theory and clinical practice of TFP as a treatment for Borderline Personality Disorder.

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.